
Morepen Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment ".
Filed with NSE ·

Morepen Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2025, titled "Empamore by Morepen: Revolutionizing Diabetes Care with Affordable, High-Quality Treatment ".
6ix hasn’t read this filing yet.
Morepen Laboratories Limited on 6ix
Follow Morepen Laboratories into a list and get an email when it puts out news.
Follow Morepen Laboratories